For research use only. Not for therapeutic Use.
PPI-1019 is a small-molecule compound investigated for its potential as a neuroprotective agent, particularly in the treatment of neurodegenerative disorders such as Parkinson’s disease. It acts as an antagonist of the sigma-1 receptor, which is involved in modulating various cellular processes, including neuroprotection, stress response, and neurotransmitter regulation. By targeting this receptor, PPI-1019 has shown promise in reducing neuroinflammation and protecting neurons from degeneration. Its potential to modulate neuroprotective pathways makes it a valuable compound in research aimed at developing therapies for diseases characterized by neuronal loss and dysfunction.
Catalog Number | I008833 |
CAS Number | 290828-45-4 |
Synonyms | PPI-1019; PPI1019; PPI 1019; Apan;(R)-N-((R)-1-(((R)-1-(((R)-1-(((R)-1-amino-4-methyl-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)-4-methyl-2-(methylamino)pentanamide |
Molecular Formula | C36H54N6O5 |
Purity | ≥95% |
Target | beta-amyloid protein inhibitor |
Solubility | Soluble in DMSO |
Storage | 0 - 4 °C for short term, or -20 °C for long term |
IUPAC Name | (2R)-4-methyl-2-[[(2R)-2-[[(2R)-2-[[(2R)-3-methyl-2-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]butanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]pentanamide |
InChI | InChI=1S/C36H54N6O5/c1-22(2)18-27(32(37)43)39-34(45)29(20-25-14-10-8-11-15-25)40-35(46)30(21-26-16-12-9-13-17-26)41-36(47)31(24(5)6)42-33(44)28(38-7)19-23(3)4/h8-17,22-24,27-31,38H,18-21H2,1-7H3,(H2,37,43)(H,39,45)(H,40,46)(H,41,47)(H,42,44)/t27-,28-,29-,30-,31-/m1/s1 |
InChIKey | TUSUWHFYKZZRIG-JQWMYKLHSA-N |
SMILES | CC(C)CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC |